share_log

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Officer Sterling O. James

SEC ·  Jul 4 04:11
Summary by Futu AI
Sterling O. James, the Chief Financial Officer of bluebird bio, Inc. [BLUE], was involved in a transaction on 07/01/2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The address provided for Sterling O. James is c/o bluebird bio, Inc, 455 Grand Union Boulevard, Somerville, MA, 02145.
Sterling O. James, the Chief Financial Officer of bluebird bio, Inc. [BLUE], was involved in a transaction on 07/01/2024. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The address provided for Sterling O. James is c/o bluebird bio, Inc, 455 Grand Union Boulevard, Somerville, MA, 02145.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.